Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 125.5 GBX Market Closed
Market Cap: 106.3m GBX
Have any thoughts about
Diaceutics PLC?
Write Note

Wall Street
Price Targets

DXRX Price Targets Summary
Diaceutics PLC

Wall Street analysts forecast DXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXRX is 178.91 GBX with a low forecast of 161.6 GBX and a high forecast of 210 GBX.

Lowest
Price Target
161.6 GBX
29% Upside
Average
Price Target
178.91 GBX
43% Upside
Highest
Price Target
210 GBX
67% Upside
Diaceutics PLC Competitors:
Price Targets
300347
Hangzhou Tigermed Consulting Co Ltd
7% Upside
DIM
Sartorius Stedim Biotech SA
20% Upside
SHC
Sotera Health Co
24% Upside
MRVI
Maravai LifeSciences Holdings Inc
80% Upside
WAT
Waters Corp
5% Upside
NANOFH
Nanoform Finland Oyj
190% Upside
LONN
Lonza Group AG
19% Upside
MLC
Malin Corporation PLC
83% Upside

Revenue
Forecast

Revenue Estimate
Diaceutics PLC

For the last 6 years the compound annual growth rate for Diaceutics PLC's revenue is 21%. The projected CAGR for the next 4 years is 25%.

21%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Diaceutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Diaceutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXRX's stock price target?
Price Target
178.91 GBX

According to Wall Street analysts, the average 1-year price target for DXRX is 178.91 GBX with a low forecast of 161.6 GBX and a high forecast of 210 GBX.

What is Diaceutics PLC's Revenue forecast?
Projected CAGR
25%

For the last 6 years the compound annual growth rate for Diaceutics PLC's revenue is 21%. The projected CAGR for the next 4 years is 25%.

Back to Top